PET Scan for Alzheimer's Disease
We offer patients PET Scan with Amyvid™, brain imaging to determine the presence of plaques related to Alzheimer’s disease and cognitive decline.
Advancement in Imaging
To evaluate if a patient has the pathology of Alzheimer’s disease or other cause of cognitive decline, a PET (positron emission tomography) scan with Amyvid™ may show the presence of beta-amyloid plaques in the brain. These plaques appear at higher levels in patients with cognitive impairment. Amyvid, an FDA-approved radiotracer, binds to the plaques, allowing detection by PET scan.
Abington Health was the first in the Philadelphia area and among the first in the nation to offer this test.
Considerations for Testing
It is recommended that the test be used with other diagnostic tools for Alzheimer’s disease, such as neuropsychiatric testing, physical examination, family history and cognitive testing. Although there is no treatment to halt the disease, being able to identify beta-amyloid plaques is a big step forward. Currently, health insurance does not cover this test, so patients must pay out of pocket. Autopsy remains the only definitive way to diagnose Alzheimer’s disease.
Through the Neurosciences Institute and Muller Institute for Senior Health, Abington Health provides a full array of services for people facing neurological and senior health issues.
For information about PET scan with Amyvid, call 215-481-MEDI.